DC Investment Partners
Venture capitalMcLean · Seed–Late Stage · 10 people tracked
Find your way into DC Investment Partners
586 people in our graph share verified history with the DC Investment Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
DC Investment Partners backs early- and growth-stage companies, seeking businesses with strong leadership, demonstrated market acceptance, and a competitive edge. The firm aims to combine intellectual and financial capital to foster innovation. Beyond funding, it offers hands-on operational support—finance, human resources, recruiting, data analysis, and market research—to help companies that lack scale focus on value-added activities. Its team brings expertise in strategy consulting, business development, and investing, applying rigorous analytical methods to build sustainable business models and identify core profit drivers.
Source: firm website, verified Aug 7, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 14 of 19 portfolio companiesBiotech ×6Deep Tech ×3Fintech ×3Healthtech ×3Medical Devices ×3AI & Machine Learning ×2Cybersecurity ×2Climate Tech ×1
HQs:United States×8Bermuda×1United Kingdom×1
Investments · 19 tracked
founders shown can be your intro pathBy year:2022 · 12021 · 12020 · 32019 · 16 dated
Aeolus Capital Management is a reinsurance manager specializing in natural catastrophe risk, providing customized collateralized property catastrophe reinsurance contracts to institutional investors and cedants.
Climate TechData & InfrastructureFintechInsurTechHamilton, BM
Andrew Bernstein(Chief Executive Officer and Head of Portfolio Management)Aditya Dutt(President)inFrank Fischer(Chief Analytics Officer)Jason McAlpine(Chief Operating Officer and Chief Financial Officer)inDaina Casling(General Counsel and Chief Compliance Officer)in
Above Security develops AI-powered investigative agents for insider risk management that continuously analyze user behavior across identity, applications, and data movement to provide high-fidelity narratives with minimal false positives.
AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareSeattle, US
Rami Habal(Co-founder & CEO)inAmit Megiddo(Co-founder and CEO)inGal Ordo(Co-founder and CPO)inEyal Faingold(Co-founder and CTO)inAviv Nahum(Co-founder & CEO)inAmir Boldo(CPTO)in
Co-investorsBallistic VenturesMunich Re Ventures
Bounce Imaging manufactures tactical 360-degree camera systems and robotics for first responders, law enforcement, and military personnel to safely assess confined spaces.
Defense TechHardwareRoboticsBuffalo, US
Francisco Aguilar(Executive Officer, Director)inRonjon Nag(Director)inJames Smist(Director)Sietse Dijkstra(Executive Officer)inMark Fargason(Executive Officer)inMikhail Fridberg(Executive Officer)in
Co-investorsIn-Q-TelBantam GroupBroad Street AngelsBrown and White VenturesGood Growth CapitalGreat Oaks Venture Capital+4 more
The page presents Pinco Casino, an online gambling platform offering slots, live casino, table games, and sports betting with a Turkish-language interface.
ConsumerGamingHealthtechBoston, US
Robert Kotin(Executive Officer, Director)Chen Schor(Director)Robert Hadfield(Executive Officer)John Lawrence(Executive Officer)
BoardGeeta Vemuri(Director)inDerek Yoon(Director)in
Co-investorsAstellas Venture Management LLCSolasta VenturesUTokyo Innovation Platform Co. Ltd.Agent CapitalLongwood Fund
Columbia Lake Partners provides growth loans to European technology companies, offering venture debt as an alternative to equity dilution.
FintechLondon, GB
Co-investorsBessemer Venture Partners
San Mateo, US
Neil Peretz(Director)John Gengarella(Executive Officer, Director)
Co-investorsAV8 Ventures
DEM BioPharma is a biotechnology company developing cancer therapies by targeting the immune system, drawing on genetic and immuno-oncology research.
BiotechHealthtechCambridge, US
Nenad Grmusa(Chief Executive Officer)inJohn McCabe(Chief Financial and Operating Officer)in
Co-investorsAlta PartnersAstellas Venture Management LLCLongwood FundPfizer Venture InvestmentsUTokyo Innovation Platform Co. Ltd.Insight Partners+1 more
Evolution Equity is an investment firm with 20+ years of experience in building and investing in cybersecurity companies.
Cybersecurity
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsAgent CapitalLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.Solasta Ventures+3 more
Kandou AI develops high-speed, energy-efficient connectivity solutions for semiconductor and AI infrastructure, focusing on reducing system costs to enable scalable AI systems.
AI & Machine LearningDeep TechSemiconductors
Co-investorsBessemer Venture PartnersForestay CapitalVerve VenturesMaverick SiliconSoftBank GroupSwisscom Ventures
.jpeg){kind=logo}
Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.
Biotech
David King(Co-Founder & CSO)inMaria Fardis(CEO)inCadmus C. Rich(Chief Medical Officer)inElaine Stracker(General Counsel)in
Co-investorsAlta PartnersCatalio Capital Management, LPLongitude CapitalLongwood FundBiotechnology Value FundCatalio Capital Management+2 more
Longwood Fund is a biotech-focused investment firm that both creates and invests in early-stage biotechnology companies developing therapies for unmet medical needs.
BiotechDeep TechMedical DevicesMental Health
Co-investorsLongwood Fund
QED is a fintech-focused venture capital and investment firm that provides advisory and capital to companies in payments, embedded finance, vertical banking, and related financial technology sectors.
Fintech
Frank Rotman(Co-Founder and Partner Emeritus)Nigel Morris(Co-Founder and Managing Partner)
Rectify Pharma is a biotechnology company developing therapies, with a pipeline that has included work in liver and metabolic disease areas.
BiotechDeep Tech
Rajesh Devraj(President and Chief Executive Officer)inRobert Hughes(Chief Scientific Officer)inPol Boudes(Chief Medical Officer)
Co-investorsAtlas VentureLongwood FundForbion
Massachusetts-based developer of millimeter-wave 5G radio access network equipment and software for operators and enterprises.
Waltham, US
Vedat Eyuboglu(Executive Officer, Director)inAmit Jain(Executive Officer, Director)
BoardSanto Politi(Director)in
Co-investorsBold Capital PartnersLockheed Martin VenturesSpark CapitalTaiwania CapitalTDK Ventures
.jpeg){kind=logo}
Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer.
BiotechHealthtechMedical DevicesWatertown, US
Daniel J. Hicklin(Founder, President, Chief Executive Officer, and Board member)Luke Evnin(Co-founder, Board member (Chairman))inDaniel Hicklin(Executive Officer, Director)David Cordo(Executive Officer)Alon Lazarus(Director)
BoardChristoph Westphal(Director)
Co-investorsK2 HealthVenturesLongwood FundMPM BioImpactRA CapitalTaiho Ventures, LLC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BE BiopharmaEdgeworthBox, Inc.visit www.interiusbio.com
Portfolio news
latest coverage across their companies
Bounce Imaging · buffalonews.com · Jul 10, 2026
Kandou · eetimes.com · Apr 7, 2026
DEM BioPharma · nasdaqprivatemarket.com · Jun 27, 2025
Frequently asked questions
- How many investments has DC Investment Partners made?
- DC Investment Partners has 19 tracked investments.
- What stage does DC Investment Partners invest at?
- DC Investment Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is DC Investment Partners's typical check size?
- DC Investment Partners typically writes checks of $10M.
- What sectors does DC Investment Partners focus on?
- DC Investment Partners focuses on Biotech, Consumer, Data & Infrastructure, Medical Devices, Sector Agnostic, Semiconductors.
- Where is DC Investment Partners located?
- DC Investment Partners is headquartered in McLean, US.
- Who does DC Investment Partners co-invest with?
- DC Investment Partners most often shares deals with Longwood Fund, Alta Partners, Astellas Venture Management LLC, among 32 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
Mitsui Global Investment is an investment firm that provides capital and hands-on support to entrepreneurs, helping innovative teams scale their businesses onto the global stage.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.